Plasmid clone of mouse sialyltransferase cDNA
Alternative name | ST60-I; GalNAC alpha 2,6-sialyltransferase |
---|---|
Clone info. | Plasmid clone of mouse sialyltransferase cDNA |
Vector backbone | pBluescript II SK(+) (Plasmid) |
Size of vector backbone | 3.0 kb |
Selectable markers | Amp^r |
Gene/insert name | Mouse ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 cDNA |
Reference of insert sequence | Y11274 (DDBJ accession number) |
Depositor|Developer | Tsuji, Shuichi | |
Additional map |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested (Ikehara, Y. et al., Glycobiology, 9, 1213-1224 (1999)). |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Ikehara, Y. et al., Glycobiology, 9, 1213-1224 (1999))。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB02092 | mST6GalNACI | DNA solution |
Materials & Methods section:
The mST6GalNACI was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB02092). |
Reference section:
Ikehara, Y., Kojima, N., Kurosawa, N., Kudo, T., Kono, M., Nishihara, S., Issiki, S., Morozumi, K., Itzkowitz, S., Tsuda, T., Nishimura, S.I., Tsuji, S., Narimatsu, H., Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology, 9, 1213-1224 (1999). PMID 10536037. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB02092_A9I6p1-1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: reverse-2 (Pr0100) Region: insert 5' Sequence file: RDB02092_A9I6a.seq |
---|
>02092_02092_A9I6_3_reverse-2_F01_16_ABI24.ab1 1 NNNNNNNNNN NNNNNNGNAA CAAAANCTGG AGCTCCACCG CGGTGGCGGC CGCTCTAGAA 61 CTAGTGGATC CCCCGGGCTG CAGGAATTCG CGGCCGCTTT TTTTTTCACC TGTGCTTTCA 121 TGAAAGCTAA GAGTCACGCT AAAGGGCAGG GCTCCCTCGC TCTCACCTGA AGGAGCAGGC 181 GATCTGACTG CTGCTTTAAG AAGCTTGCTC TCATCATACA TGCTGTTAGG GACCAGCCAT 241 CCACCATGAC GAGATATTGC AGAGGACTTT CCCAGAGGCA AGCTTTCCTG CTTCTGACTG 301 TGTTGGCATT GCTCTTTATT CTGCTCTTCG TTGTTAAGGA TCCAAGGGCA AAAGATTCCA 361 GGTGCCAGTT CATATGGAAG AATGACGCAA GTGCCCAGGA GAATCAACAA AAGGCTGAGC 421 CCCAAGTACC CATCATGACA CTGTCACCCA GAGTTCACAA CAAGGAGACA ACCTCTGTCA 481 GTTCAAAGGA CCTGAAGAAA CAGGAGAGAG AGGCAGTCCA AGGAGAGCAA GCTGAGGGGA 541 AGGAGAAGAG GAAGTTAGAG ACCATAAGGC CAGCACCAGA GAATCCTCAG AGCAAGGCAG 601 AGCCTGCTGC AAAGACGCCT GTGTCAGAAC ACCTGGACAA ACTACCCAGA ACTCCAGGAG 661 CACTGTCAAC AAGGAAGACA CCAATGGCCA CAGGAGCTGT CCCAGCTAAG AAGAAAGTGN 721 TCCAGGCTAC CAAATCCCCT GCCTCTTCCC CACACCCCAC CACACGAANA ANGNAAAGGC 781 TGAANGCCTC TGANTTCAAG TCTGANCCTC GGNGGGATTT TGAGGAGGAA TATAGCTNNN 841 ATATGANCAG CCNGCAGANG ANNTGCTCTG CTNCTGNNAA GATCAANGNC TNCNANNCAC 901 CANGGNTACN GANTANCTTT CTGNCNNNNA TCNNTCNNNN NCNGGNNNNN NNNNN // |
Primer: pUC-M13_-100 (Pr0310) Region: insert 3' Sequence file: RDB02092_A9I6b.seq |
>02092_02092_A9I6_3_pUC-M13_-100_C03_03_ABI08.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNGTTTNN NNNNNNNNNG NNGTTGTAAA 61 ACGACGGCCA GTGNGCGCGC GTAATACGAC TCACTATAGG GCGAATTGGG TACCGGGCCC 121 CCCCTCGAGA TCTGGAATTC GAGCTCGGTA CCCGTTGAAA GGTGTGGAGC AGGTCTGATT 181 CCAGAGACAC AGGTAGGAGC ATTTGAGGAG CCCTTGCATT CTGTGTTGTA AGTGGTCGAG 241 GGGAACACCC TGATCTGGGC CCTGGTCAGT TCTTTGCTTT GTCACTTTGT GGACGCTGGT 301 AGAGCCAGAT GATGCCTTCA TCATGCAACC GCTTCCACAC CATTCTCTCT AACCTGAAGT 361 CATGGTTGAT ATAAAAGATG AGCCGTTTCC ATGATGTATC ATAGTAGTGG TCAGAGAAGC 421 GCTGGTGGCC CTCGGTGATG AAGCCATAGG CGCTGACCTT GTCACAGAGA TGAAGGGCTG 481 TGAGCAGCAG GAGGGCACCA GTGGTGGGGC GGTATATTCT CCAATGGGCA GTGTCCAGGG 541 TCTTTGACCT CAGAAACCTG TTCTTCATGT AACGGAGAAA GTCTGGGTGC AGCAGCAAGT 601 ATCGATCCAA GTCCAAGGCA TTCCGGAAGG CTTCCTGAGG CCTATGCCTG AACCAGGAAA 661 GGTGGGTTTT TGCCAAGGTC TGATTCNA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Ikehara, Y., Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology, 9, 1213-1224 (1999). PMID 10536037. [link to RRC of NBRP] |
---|
Featured content